Cypress, the Cypress logo and WICED are registered trademarks of Cypress Semiconductor Corporation. All other trademarks are property of their owners.
CYPRESS SEMICONDUCTOR CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands) (Unaudited) |
|||||||
October 1, 2017 | January 1, 2017 | ||||||
ASSETS | |||||||
Cash, cash equivalents and short-term investments | $ | 131,563 | $ | 121,144 | |||
Accounts receivable, net | 356,453 | 333,037 | |||||
Inventories | 286,981 | 287,776 | |||||
Property, plant and equipment, net | 286,881 | 297,266 | |||||
Goodwill and other intangible assets, net | 2,196,390 | 2,344,033 | |||||
Other assets | 442,274 | 488,615 | |||||
Total assets | $ | 3,700,542 | $ | 3,871,871 | |||
LIABILITIES AND EQUITY | |||||||
Accounts payable | $ | 210,148 | $ | 241,424 | |||
Income tax liabilities | 57,403 | 49,552 | |||||
Revenue reserves, deferred margin and other liabilities | 480,802 | 493,164 | |||||
Revolving credit facility and long-term debt | 1,103,875 | 1,194,979 | |||||
Total liabilities | 1,852,228 | 1,979,119 | |||||
Total Cypress stockholders' equity | 1,847,246 | 1,891,828 | |||||
Non-controlling interest | 1,068 | 924 | |||||
Total equity | 1,848,314 | 1,892,752 | |||||
Total liabilities and equity | $ | 3,700,542 | $ | 3,871,871 | |||
CYPRESS SEMICONDUCTOR CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS ON A GAAP BASIS (In thousands, except per-share data) (Unaudited) |
||||||||
Three Months Ended | ||||||||
October 1, 2017 | July 2, 2017 | |||||||
Revenues | $ | 604,574 | $ | 593,776 | ||||
Costs and expenses: | ||||||||
Cost of revenues | 351,969 | 357,594 | ||||||
Research and development | 91,334 | 89,736 | ||||||
Selling, general and administrative | 73,746 | 82,141 | ||||||
Amortization of intangible assets | 48,428 | 49,354 | ||||||
Costs and settlement charges related to shareholder matter | — | 12,043 | ||||||
Total costs and expenses | 565,477 | 590,868 | ||||||
Operating income | 39,097 | 2,908 | ||||||
Interest and other expense, net | (18,619 | ) | (16,407 | ) | ||||
Income (loss) before income taxes and non-controlling interest | 20,478 | (13,499 | ) | |||||
Income tax provision | (4,500 | ) | (4,504 | ) | ||||
Equity in net loss of equity method investees | (4,931 | ) | (4,835 | ) | ||||
Net income (loss) | 11,047 | (22,838 | ) | |||||
Net gain attributable to non-controlling interests | (14 | ) | (66 | ) | ||||
Net income (loss) attributable to Cypress | $ | 11,033 | $ | (22,904 | ) | |||
Net income (loss) per share attributable to Cypress: | ||||||||
Basic | $ | 0.03 | $ | (0.07 | ) | |||
Diluted | $ | 0.03 | $ | (0.07 | ) | |||
Cash dividend declared per share | $ | 0.11 | $ | 0.11 | ||||
Shares used in net income (loss) per share calculation: | ||||||||
Basic | 332,873 | 329,860 | ||||||
Diluted | 360,311 | 329,860 | ||||||
CYPRESS SEMICONDUCTOR CORPORATION RECONCILIATION OF GAAP FINANCIAL MEASURES TO NON-GAAP FINANCIAL MEASURES (In thousands, except per-share data) (Unaudited) |
||||||||||||||||||||||||
Table A: GAAP to Non-GAAP reconciling items: Three Months Ended Q3 2017 |
||||||||||||||||||||||||
Cost of
|
Research and
|
SG&A and
|
Amortization
|
Interest and
|
Income tax
|
|||||||||||||||||||
GAAP [i] | $ | 351,969 | $ | 91,334 | $ | 73,746 | $ | 48,428 | $ | (23,550 | ) | $ | (4,500 | ) | ||||||||||
[1] Stock based compensation | 5,156 | 9,604 | 8,235 | — | — | — | ||||||||||||||||||
[2] Changes in value of deferred compensation plan | 208 | 1,278 | 1,415 | — | (1,734 | ) | — | |||||||||||||||||
[3] Merger, integration, related costs and adjustments related to assets held for sale | 1,336 | — | (636 | ) | — | — | — | |||||||||||||||||
[4] Inventory step-up related to acquisition accounting | 704 | — | — | — | — | — | ||||||||||||||||||
[5] Losses from equity method investments | — | — | — | — | 4,931 | — | ||||||||||||||||||
[6] Imputed interest on convertible debt, equity component amortization on convertible debt and others | — | — | — | — | 3,521 | — | ||||||||||||||||||
[7] Write-off of unamortized debt issuance costs related to Term Loan A | — | — | — | — | 2,996 | — | ||||||||||||||||||
[8] Amortization of debt issuance costs |
— |
— | — | — | 856 | — | ||||||||||||||||||
[9] Amortization of intangible assets |
— |
— | — | 48,428 | — | — | ||||||||||||||||||
[10] Tax impact | — | — | — | — | 51 | 1,598 | ||||||||||||||||||
Non - GAAP [ii] | $ | 344,565 | $ | 80,452 | $ | 64,732 | $ | — | $ | (12,929 | ) | $ | (2,902 | ) | ||||||||||
Impact of reconciling items [ii - i] | $ | (7,404 | ) | $ | (10,882 | ) | $ | (9,014 | ) | $ | (48,428 | ) | $ | 10,621 | $ | 1,598 | ||||||||
Table B: GAAP to Non-GAAP reconciling items: Three Months Ended Q2 2017 |
||||||||||||||||||||||||||||
Cost of
|
Research
|
SG&A and
|
Costs and
|
Amortization
|
Interest and
|
Income tax
|
||||||||||||||||||||||
GAAP [i] | $ | 357,594 | $ | 89,736 | $ | 82,141 | $ | 12,043 | $ | 49,354 | $ | (21,242 | ) | $ | (4,504 | ) | ||||||||||||
[1] Stock based compensation | 4,833 | 11,274 | 14,226 | — | — | — | — | |||||||||||||||||||||
[2] Changes in value of deferred compensation plan | 137 | 563 | 896 | — | — | (1,584 | ) | — | ||||||||||||||||||||
[3] Merger, integration, related costs and adjustments related to assets held for sale | 1,336 | (96 | ) | 1,193 | — | — | — | — | ||||||||||||||||||||
[4] Inventory step-up related to acquisition accounting | 167 | — | — | — | — | — | — | |||||||||||||||||||||
[5] Losses from equity method investments | — | — | — | — | — | 4,835 | — | |||||||||||||||||||||
[6] Settlement charges | — | — | 3,500 | — | — | — | ||||||||||||||||||||||
[7] Imputed interest on convertible debt, equity component amortization on convertible debt and others | — | — | — | — | — | 3,507 | — | |||||||||||||||||||||
[8] Amortization of debt issuance costs | — | — | — | — | — | 920 | — | |||||||||||||||||||||
[9] Amortization of intangible assets |
— |
— | — | — | 49,354 | — | — | |||||||||||||||||||||
[10] Restructuring costs | — | — | 898 | — | — | — | — | |||||||||||||||||||||
[11] Tax impact | — | — | — | — | — | 227 | 1,421 | |||||||||||||||||||||
Non - GAAP [ii] | $ | 351,121 | $ | 77,995 | $ | 64,928 | $ | 8,543 | $ | — | $ | (13,337 | ) | $ | (3,083 | ) | ||||||||||||
Impact of reconciling items [ii - i] |
$ | (6,473 | ) | $ | (11,741 | ) | $ | (17,213 | ) | $ | (3,500 | ) | $ | (49,354 | ) | $ | 7,905 | $ | 1,421 | |||||||||
Table C: Margin % |
||||||||||||||||
Q3'17 | Q2'17 | |||||||||||||||
GAAP | Non-GAAP | GAAP | Non-GAAP | |||||||||||||
Revenue [i] | $ | 604,574 | $ | 604,574 | $ | 593,776 | $ | 593,776 | ||||||||
Cost of revenues (See Table A, B) [ii] | 351,969 | 344,565 | 357,594 | 351,121 | ||||||||||||
Margin [iii] [ii - i] | $ | 252,605 | $ | 260,009 | $ | 236,182 | $ | 242,655 | ||||||||
Margin % [iii / i] | 41.8 | % | 43.0 | % | 39.8 | % | 40.9 | % | ||||||||
Table D: Operating income |
|||||||
Q3'17 | Q2'17 | ||||||
GAAP operating income [i] | $ | 39,097 | $ | 2,908 | |||
Impact of reconciling items on Cost of revenues (see Table A, B) | 7,404 | 6,473 | |||||
Impact of reconciling items on R&D (see Table A, B) | 10,882 | 11,741 | |||||
Impact of reconciling items on SG&A (see Table A, B) | 9,014 | 17,213 | |||||
Settlement charges (Table B) | — | 3,500 | |||||
Impact of Amortization of Intangible Assets (see Table A, B) | 48,428 | 49,354 | |||||
Non-GAAP operating income [ii] | $ | 114,825 | $ | 91,189 | |||
Impact of reconciling items [ii - i] | $ | 75,728 | $ | 88,281 | |||
Table E: Pre-tax profit |
||||||||
Q3'17 | Q2'17 | |||||||
GAAP Pre-tax income (loss) | $ | 15,547 | $ | (18,334 | ) | |||
Impact of reconciling items on Operating income (see Table D) | 75,728 | 88,281 | ||||||
Interest and other expense, net (see Table A, B) | 10,621 | 7,905 | ||||||
Non-GAAP Pre-tax income | $ | 101,896 | $ | 77,852 | ||||
Table F: Net income (loss) |
||||||||
Q3'17 | Q2'17 | |||||||
GAAP Net income (loss) | $ | 11,033 | $ | (22,904 | ) | |||
Impact of reconciling items on Operating income (see Table D) | 75,728 | 88,281 | ||||||
Interest and other expense, net (see Table A, B) | 10,621 | 7,905 | ||||||
Income tax benefit (see Table A, B) | 1,598 | 1,421 | ||||||
Non-GAAP Net income | $ | 98,980 | $ | 74,703 | ||||
Table G: Pretax profit margin % |
||||||||||||||||
Q3'17 | Q2'17 | |||||||||||||||
GAAP | Non-GAAP | GAAP | Non-GAAP | |||||||||||||
Revenue [i] | $ | 604,574 | $ | 604,574 | $ | 593,776 | $ | 593,776 | ||||||||
Pre-tax profit (loss) (see Table E) [ii] | $ | 15,547 | $ | 101,896 | $ | (18,334 | ) | $ | 77,852 | |||||||
Pre-tax profit margin % [ii / i] | 2.6 | % | 16.9 | % | (3.1 | )% | 13.1 | % | ||||||||
Table H: Weighted-average shares, diluted |
|||||||||||
Q3'17 | Q2'17 | ||||||||||
GAAP | Non-GAAP | GAAP | Non-GAAP | ||||||||
Weighted-average common shares outstanding, basic | 332,873 | 332,873 | 329,860 | 329,860 | |||||||
Effect of dilutive securities: | |||||||||||
Stock options, unvested restricted stock and other | 7,884 | 12,948 | — | 15,822 | |||||||
Impact of convertible bond | 19,554 | 18,790 | — | 18,208 | |||||||
Weighted-average common shares outstanding, diluted | 360,311 | 364,611 | 329,860 | 363,890 | |||||||
Table I: Net income (loss) Per Share |
|||||||||||||||
Q3'17 | Q2'17 | ||||||||||||||
GAAP | Non-GAAP | GAAP | Non-GAAP | ||||||||||||
Net income (loss) (see Table F) [i] | $ | 11,033 | $ | 98,980 | $ | (22,904 | ) | $ | 74,703 | ||||||
Weighted-average common shares outstanding (see Table H) [ii] | 360,311 | 364,611 | 329,860 | 363,890 | |||||||||||
Non-GAAP earnings per share - Diluted [i/ii] | $ | 0.03 | $ | 0.27 | $ | (0.07 | ) | $ | 0.21 | ||||||
CYPRESS SEMICONDUCTOR CORPORATION SUPPLEMENTAL FINANCIAL DATA (In thousands) (Unaudited) |
||||||||
Three Months Ended | ||||||||
October 1, 2017 | July 2, 2017 | |||||||
Selected Cash Flow Data (Preliminary): |
||||||||
Net cash provided by operating activities | $ | 143,778 | $ | 32,447 | ||||
Net cash (used in) provided by investing activities | $ | (15,051 | ) | $ | (14,992 | ) | ||
Net cash used in financing activities | $ | (105,935 | ) | $ | (30,184 | ) | ||
Other Supplemental Data (Preliminary): |
||||||||
Capital expenditures | $ | (17,144 | ) | $ | 15,577 | |||
Depreciation | $ | 16,674 | $ | 16,045 | ||||
Payment of dividend | $ | 36,325 | $ | 36,217 | ||||
Dividend paid per share | $ | 0.11 | $ | 0.11 | ||||
CYPRESS SEMICONDUCTOR CORPORATION
RECONCILIATION OF GAAP FORWARDING LOOKING ESTIMATES TO NON-GAAP
FORWARD LOOKING
|
||||||||||||||||||||
Forward looking
|
Adjustments (B) |
Forward looking
|
||||||||||||||||||
Amortization of
|
Share-based
|
Restructuring |
Other
|
|||||||||||||||||
Margin % | 42.0% - 43.0% | — | % | 1.0 | % | — | % | 0.2 | % | 43.0% - 44.0% | ||||||||||
Diluted earnings per share | $(0.01) to $0.03 | $ | 0.13 | $ | 0.07 | $ | — | $ | 0.04 | $0.23 to $0.27 |